Adjuvant therapy of resected non-small-cell lung cancer

Steven M. Keller

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


The administration of adjuvant therapy after complete resection of non-small-cell lung cancer is controversial. Radiation therapy and chemotherapy have been used individually and concomitantly in efforts to prevent local recurrence and improve survival. However, recent phase II and III trials and a meta-analysis have produced conflicting results. Postoperative adjuvant therapy remains a subject of active investigation.

Original languageEnglish (US)
Pages (from-to)149-155
Number of pages7
JournalCurrent Opinion in Oncology
Issue number2
StatePublished - 2000

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Adjuvant therapy of resected non-small-cell lung cancer'. Together they form a unique fingerprint.

Cite this